nach oben

Erschienen in:

01.07.2008 | Original Paper

Stimulant Injectors in Ukraine: The Next Wave of the Epidemic?

verfasst von: Robert E. Booth, Wayne E. K. Lehman, Carol F. Kwiatkowski, John T. Brewster, Larisa Sinitsyna, Sergey Dvoryak

Erschienen in: AIDS and Behavior | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

This study was designed to assess differences in drug and sex-related risk behaviors between injectors of opiates only, opiate/sedative mix only and stimulants only. Participants were current out-of-treatment injection drug users (IDUs), unaware of their HIV status, recruited through street outreach in Kiev, Odessa and Makeevka/Donetsk, Ukraine. Overall, 22% tested positive for HIV, including 39% among opiate/sedative injectors, 19% among opiate injectors and 17% among stimulant injectors. Despite these differences, stimulant injectors were at higher risk than other IDUs in sharing a used needle/syringe, always injecting with others, injecting a drug solution drawn from a common container, having an IDU sex partner, not using condoms during vaginal or anal sex and on composite measures of injection and sex risks. After controlling for age differences, stimulant injectors remained at higher risk in their needle and sex risk behaviors. Without intervention, it is likely that HIV will increase among stimulant injectors.

Atlani, L., Carael, M., Brunet, J. B., Frasca, T., & Chaika, N. (2000). Social change and HIV in the former USSR: The making of a new epidemic. Social Science and Medicine, 50, 1547–1556.PubMedCrossRef

Ball, A., Rana, S., & Dehne, K. L. (1998). HIV prevention among injecting drug users: Responses in developing and transitional countries. Public Health Report, 113(Suppl. 1), 170–181.

Barnett, T., Whiteside, A., Khodakevich, L., Kruglov, Y., & Steshenko, V. (2000). The HIV/AIDS epidemic in Ukraine: Its potential social and economic impact. Social Science and Medicine, 51, 1387–1403.PubMedCrossRef

Boddiger, D. (2005). Methamphetamine use linked to rising HIV transmission. The Lancet, 365, 1217–1218.CrossRef

Booth, R. E., Kennedy, J., Brewster, T., & Semerik, O. (2003). Drug injectors and dealers in Odessa, Ukraine. Journal of Psychoactive Drugs, 35, 419–426.PubMed

Booth, R. E., Kwiatkowski, C. F., Brewster, J. T., Sinitsyna, L., & Dvoryak, S. (2006). Predictors of HIV sero-status among drug injectors at three Ukraine sites. AIDS, 20, 2217–2223.PubMedCrossRef

Booth, R. E., Mikulich-Gilbertson, S. K., Brewster, J. T., Salomonson-Sautel, S., & Semerik, O. (2004). Predictors of self-reported HIV infection among drug injectors in Ukraine. Journal of the Acquired Immune Deficiency Syndromes, 35, 82–88.CrossRef

Booth, R. E., Crowley, T. J., & Zhang, Y. (1996). Substance abuse treatment entry, retention and effectiveness: Out-of-treatment opiate injection drug users. Drug and Alcohol Dependence, 42(1), 11–20.PubMedCrossRef

Carlson, R. G., Wang, J., Siegal, H. A., Falck, R. S., & Guo, J. (1994). An ethnographic approach to targeted sampling: Problems and solutions in AIDS prevention research among injection drug and crack-cocaine users. Human Organization, 53, 279–286.

Centers for Disease Control and Prevention. (2005). Specific populations: How are they affected? HIV prevention in the third decade. Atlanta, Georgia.

Chaisson, R. E., Bacchetti, P., Osmond, D., Brodie, B., Sande, M. A., & Moss, A. R. (1989). Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA, 261(4), 561–565.PubMedCrossRef

Chintalova-Dallas, R., Lutzenko, D., Lazzarini, Z., & Case, P. (2006). Boltuska: Use of homemade amphetamine in Odessa, Ukraine. Second annual methamphetamine conference. Salt Lake City.

Coyle, S. (1993). The NIDA HIV counseling and education intervention model: Intervention manual (No. NIH Publication No. 93–3580). U.S. Department of Health and Human Services, GPO.

DeBell, D., & Carter, R. (2005). The impact of transition on public health in Ukraine: A case study of the HIV/AIDS epidemic. British Medical Journal, 331, 216–219.PubMedCrossRef

Dehne, K. L., Grund, J. C., Khodakevich, L., & Kobyshcha, Y. (1999). The HIV/AIDS epidemic among drug injectors in Eastern Europe: Patterns, trends and determinants. Journal of Drug Issues, 29, 729–776.

Dowling-Guyer, S., Johnson, M. E., Fisher, D. G., Needle, R., Watters, J., Andersen, M., Williams, M., Kotranski, L., Booth, R., Rhodes, F., Weatherby, N., Estrada, A. L., Fleming, D., Deren, S., & Tortu, S. (1994). Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment, 1(4), 383–392.

EuroHIV. (2005). HIV/AIDS surveillance in Europe: End-year report 2005. Saint-Maurice: Institute de Veille Sanitaire.

Guydish, J. R., Abramowitz, A., Woods, W., Black, D. M., & Sorenson, J. L. (1990). Changes in needle sharing among intravenous drug users: San Francisco 1986–88. American Journal of Public Health, 80, 995–997.PubMedCrossRef

Hamers, F. F., & Downs, A. M. (2003). HIV in Central and Eastern Europe. The Lancet, 361, 1035–1044.CrossRef

Hamers, F. F., Batter, V., Downs, A. M., Alix, J., Cazien, F., & Brunet, J. B. (1997). The HIV epidemic associated with injecting drug use in Europe: Geographic and time trends. AIDS, 11, 1365–1374.PubMedCrossRef

Hoffman, J.P., Su, S.S., & Pach, A. (1997) Changes in network characteristics and HIV risk behaviors among injection drug users. Drug and Alcohol Dependence, 46, 41–51.CrossRef

Khodakevich, L., & Dehne, K. L. (1998). HIV epidemics in drug-using populations and increasing drug use in Central and Eastern Europe. Global research network meeting on HIV prevention in drug-using populations. Geneva.

Kozlov, A. P., Shaboltas, A. V., Toussova, O. V., Verevochkin, S. V., Masse, B. R., & Perdue, T. (2002). HIV incidence and factors associated with HIV acquisition among injection drug users in St. Petersburg, Russia. AIDS, 20, 895–900.

Liitsolva K., Tashinova I., Laukkanen T., Korovina G., Smolskaja T., Momot O., Mashkilleyson N., Chaplinskas S., Brummer-Korvenkontio H., Vanhatalo J., Leninikki P., & Salminen, M.O. (1998). HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS, 12, 1907–1919.CrossRef

Maisto, S., McKay, J., & Conners, G. (1990). Self-reported issues in substance abuse: State of the art and future directions. Behavioral Assessment, 121, 117–134.

MAP Symposium on Eastern Europe. (1998). The determinants of the HIV/AIDS epidemics in Eastern Europe. Twelfth world AIDS conference. Geneva.

Ministry of Health Ukraine. (2006). HIV-infection in Ukraine: Information Bulletin No. 26. Kiev, Ukraine: Ukrainian AIDS Center, L.V. Gromashevskogo Institute of Epidemiology, Central Sanitary Epidemiological State if the Ministry of Health of Ukraine.

National Institute on Drug Abuse. (2002). Methamphetamine abuse and addiction. Research Report, NIH Publication No. 02–4210.

Pozynyak, V. B., Pelipas, V. E., Vievski, A. N., & Miroshnichenko, L. (2002). Illicit drug use and its health consequences in Belarus, Russian Federation and Ukraine: Impact of transition. European Addiction Research, 8, 184–189.CrossRef

Rhodes, T., Lowndes, C., Judd, A., Mikhailova, L. A., Sarang, A., Rylkov, A., Tichonov, M., Lewis, K., Ulyanova, N., Alpatova, T., Karavashkin, V., Khutorskoy, M., Hickman, M., Parry, J.V., & Renton, A. (2002). Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS, 16(13), F25–F31.PubMedCrossRef

Rhodes, T., Sarang, A., Bobrik, A., Bobkov, E., & Platt, L. (2004). HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation. International Journal of Drug Policy, 15, 1–16.CrossRef

Rhodes, T., Stimson, G. V., Crofts, N., Ball, A., Dehne, K., & Khodakevich, L. (1999). Drug injecting, rapid HIV spread, and the ‘risk environment’: Implications for assessment and response. AIDS, 13(Suppl. A), S259–S269.PubMed

Scherbinska, A. (2006). HIV infection in Ukraine: A review of epidemiological data. XVI International AIDS Conference. Vancouver.

Schoenbaum, E. E., Hartel, D., Selwyn, P. A., Klein, R. S., Davenny, K., Rogers, M., Feiner, C., & Friedland, G. (1989). Risk factors for human immunodeficiency virus infection in intravenous drug users. New England Journal of Medicine, 321(13), 874–879.PubMedCrossRef

Somlai, A. M., Kelly, J. A., Benotsch, E., Gore-Felton, C., Ostrovski, D., McAuliffe, T., & Kozlov, A.P. (2002). Characteristics and predictors of HIV risk behaviors among injection-drug using men and women in St. Petersburg Russia. AIDS Education and Prevention, 14, 295–305.PubMedCrossRef

Twitchell, G. R., Huber, A., Reback, C. J., & Shoptaw, S. (2002). Comparison of general and detailed HIV risk assessments among methamphetamine abusers. AIDS and Behavior, 6(2), 153–162.CrossRef

Ukraine Center for AIDS Prevention and Ministry for Health of Ukriane/UNAIDS. (1999). Ukraine and the AIDS Epidemic. Kiev: UNAIDS.

UNAIDS/WHO and Joint United Nations Program on HIV/AIDS. (2002). AIDS epidemic update 2002. Geneva, Switzerland: UNAIDS and WHO.

UNAIDS/WHO. (2006). Progress in scaling up access to HIV treatment in low- and middle income countries, June 2006. Fact Sheet. Geneva: UNAIDS and WHO.

UNDP. (1999). Human Development Report 1999. New York: Oxford University Press.

UNICEF. (1999). After the fall: The human impact of ten years if transition. The Monee Project CSS/CIS. Florence: UNICEF, International Child Development Centre.

UNIDCP. (1997). United Nations International Drug Control Program: World Drug Report. New York: Oxford University Press.

United Nations. (1997). Economic Commission for Europe, Trends in Europe and North America 1996/1997. Geneva: The Statistical Yearbook.

USAID. (2002). HIV/AIDS in Ukraine: A USAID Brief. Washington, DC: TvT Associates—The Synergy Project.

Walker, N., Garcia-Calleja, J. M., Heaton, L., Asamoah-Odei, E., Poumerol, G., Lazzari, S. Ghys, P. D., Schwartlander, B., & Stanecki, K. A. (2001). Epidemiological analysis of the quality of HIV sero-surveillance in the world: How well do we track the epidemic? AIDS, 15, 1545–1554.

Weatherby, N. L., Needle, R., Cesari, H., Booth, R., McCoy, C. B., Watters, J. K., Williams, M., & Chitwood, D. D. (1994). Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Evaluation and Program Planning, 17(4), 347–355.CrossRef

WHO. (1995). The current global situation of the HIV/AIDS pandemic. Weekly Epidemiological Record, 70, 355 (Geneva).

Wiebel, W. W. (1988). Combining ethnographic and epidemiological methods in targeted AIDS interventions: The Chicago model. In R. J. Battjes & R. W. Pickens (Eds.), Needle sharing among intravenous drug users: National and international perspectives (pp. 137–150). Washington, DC: U.S. Government Printing Office, National Institute on Drug Abuse Monograph No. 80.

Wiebel, W., Ouellet, L., Guydan, C., & Samairat, N. (1990) Cocaine injection as a predictor of HIV risk behaviors. XI International Conference on AIDS. Vancouver.

Titel: Stimulant Injectors in Ukraine: The Next Wave of the Epidemic?
verfasst von: Robert E. Booth
Wayne E. K. Lehman
Carol F. Kwiatkowski
John T. Brewster
Larisa Sinitsyna
Sergey Dvoryak
Publikationsdatum: 01.07.2008
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 4/2008
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-008-9359-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2008

HIV/AIDS Behavioral Surveillance among Angolan Military Men

Behavioral Studies of Female Sex Workers in China: A Literature Review and Recommendation for Future Research

Risk Behaviors of Homeless Men in India: A Potential Bridge Population for HIV Infection

Sexual Risk and Bridging Behaviors Among Young People in Hai Phong, Vietnam

High Levels of Risk Behavior Among People Living with HIV Initiating and Waiting to Start Antiretroviral Therapy in Cape Town South Africa